These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6232001)

  • 1. Relationships between suppressor macrophages and macrophage precursors in the spleens from tumor-bearing mice.
    Shibata Y; Shibuya E; Ishida N
    Cell Immunol; 1984 Apr; 85(1):45-57. PubMed ID: 6232001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of bone marrow depletion on prostaglandin E-producing suppressor macrophages in mouse spleen.
    Shibata Y; Volkman A
    J Immunol; 1985 Dec; 135(6):3897-904. PubMed ID: 2933455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential induction of prostaglandin E2-dependent and -independent immune suppressor cells by tumor-derived GM-CSF and M-CSF.
    Oghiso Y; Yamada Y; Ando K; Ishihara H; Shibata Y
    J Leukoc Biol; 1993 Jan; 53(1):86-92. PubMed ID: 7678847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of hemopoietic microenvironment on splenic suppressor macrophages in congenitally anemic mice of genotype Sl/Sld.
    Shibata Y; Volkman A
    J Immunol; 1985 Dec; 135(6):3905-10. PubMed ID: 4067308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage-derived prostaglandin E modulation of the mixed-lymphocyte reaction: an anomaly of increased production and decreased T-cell susceptibility during tumor growth.
    Denbow CJ; Conroy JM; Elgert KD
    Cell Immunol; 1984 Mar; 84(1):1-13. PubMed ID: 6230157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased sensitivity of tumor-bearing host macrophages to interleukin-10: a counter-balancing action to macrophage-mediated suppression.
    Alleva DG; Burger CJ; Elgert KD
    Oncol Res; 1994; 6(4-5):219-28. PubMed ID: 7841545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of macrophage suppressor activity by fibrosarcoma-derived transforming growth factor-beta 1: contrasting effects on resting and activated macrophages.
    Alleva DG; Walker TM; Elgert KD
    J Leukoc Biol; 1995 Jun; 57(6):919-28. PubMed ID: 7790775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor growth changes the contribution of granulocyte-macrophage colony-stimulating factor during macrophage-mediated suppression of allorecognition.
    Walker TM; Yurochko AD; Burger CJ; Elgert KD
    Immunobiology; 1992 Sep; 185(5):427-39. PubMed ID: 1452214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion of macrophages expressing I-J antigen results in efficient generation of alloreactive cytotoxic T lymphocytes.
    Kobayashi H; Aso H; Ishida N; Maeda H; Pollard RB; Suzuki F
    Cell Immunol; 1990 Jul; 128(2):589-602. PubMed ID: 2162738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrosarcoma-induced increase in macrophage tumor necrosis factor alpha synthesis suppresses T cell responses.
    Alleva DG; Askew D; Burger CJ; Elgert KD
    J Leukoc Biol; 1993 Aug; 54(2):152-60. PubMed ID: 8360594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of indomethacin on the activation and effector function of suppressor cells from tumor-bearing mice.
    Pope BL
    Cancer Immunol Immunother; 1985; 19(2):101-8. PubMed ID: 3157436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of alloreactivity by Mac-1+, -2+, and -3+ macrophages from normal and tumor-bearing hosts: flow cytofluorometrically separated macrophages.
    Askew D; Burger CJ; Elgert KD
    Immunobiology; 1990 Dec; 182(1):1-10. PubMed ID: 2151512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor modulation of autoreactivity: decreased macrophage and autoreactive T cell interactions.
    Yurochko AD; Burger CJ; Elgert KD
    Cell Immunol; 1990 Apr; 127(1):105-19. PubMed ID: 2138515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor growth increases Ia- macrophage synthesis of tumor necrosis factor-alpha and prostaglandin E2: changes in macrophage suppressor activity.
    Alleva DG; Burger CJ; Elgert KD
    J Leukoc Biol; 1993 May; 53(5):550-8. PubMed ID: 8388910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of suppressor cells by low molecular weight factors secreted by spleen cells of tumor-bearing mice: modulatory role of prostaglandins.
    Pillay DJ; Karmazyn M; Pope BL
    Int J Immunopharmacol; 1986; 8(2):227-35. PubMed ID: 2940193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo analysis of the suppressive effects of immunosuppressive acidic protein, a type of alpha 1-acid glycoprotein, in connection with its high level in tumor-bearing mice.
    Shibata Y; Tamura K; Ishida N
    Cancer Res; 1983 Jun; 43(6):2889-96. PubMed ID: 6221795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressor function of liver mononuclear cells isolated during murine chronic graft-vs-host disease. II. Role of prostaglandins and interferon-gamma.
    Howell CD; Yoder TY; Vierling JM
    Cell Immunol; 1992 Mar; 140(1):54-66. PubMed ID: 1531454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of immune responses by T cell subsets. Role of helper and suppressor T cells in the development and expression of MHC-restricted antibody responses to L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT) by (responder X responder)F1 spleen cells.
    Lake JP; Kapp JA; Pierce CW
    J Immunol; 1986 Feb; 136(4):1201-9. PubMed ID: 2418108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressor cell activity in tumor-bearing mice. I. Dualistic inhibition by suppressor T lymphocytes and macrophages.
    Elgert KD; Farrar WL
    J Immunol; 1978 Apr; 120(4):1345-53. PubMed ID: 305939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-induced variations in a high molecular weight inhibitory monokine.
    Malick AP; Yurochko AD; Burger CJ; Askew D; Elgert KD
    Immunobiology; 1989 Feb; 178(4-5):361-79. PubMed ID: 2785483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.